Peri-implantation mouse embryos: An in vitro assay for assessing serum- associated embryotoxicity in women with reproductive disorders

Reproductive Toxicology

Volumn 12, Issue 2, 1998, Pages 155-159

  Fein, Amos ^a   Carp, Howard ^a   Torchinsky, Arkady ^a   Koifman, Mara ^a   Yacobovich, Ronit ^a   Toder, Vladimir ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FETAL ANTIGEN; GROWTH FACTOR; TERATOGENIC AGENT;

ADULT; ANIMAL; BIOASSAY; BLOOD; CONFERENCE PAPER; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; EMBRYO; EMBRYO DEVELOPMENT; EMBRYOTOXICITY; FEMALE; FEMALE INFERTILITY; FETUS DEATH; HUMAN; IN VITRO STUDY; METHODOLOGY; MOUSE; NIDATION; PREGNANCY; PREGNANCY TERMINATION; PREIMPLANTATION EMBRYO; RECURRENT ABORTION; SEROLOGY; TISSUE CULTURE;

ABORTION, HABITUAL; ADULT; ANIMALS; BIOLOGICAL ASSAY; CULTURE TECHNIQUES; EMBRYO; EMBRYONIC DEVELOPMENT; FEMALE; HUMANS; INFERTILITY, FEMALE; MICE; PREGNANCY; TERATOGENS;

ANIMALIA;

EID: 0032034161     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0890-6238(97)00144-5     Document Type: Conference Paper

References (38)

1. 1. Chavez DJ, McIntyre JA. Sera from women with histories of repeated pregnancy losses cause abnormalities in mouse peri-implantation blastocysts. J Reprod Immunol. 1984;6:273-81.
2. 2. Oksenberg JR, Brautbar C. In vitro suppression of marine blastocysts growth by sera from women with reproductive disorders. Am J Reprod Immunol Microbiol. 1986;11:118-24.
3. 3. Carlino JA, Morse JH. Pregnancy associated growth factor. II. A T-dependent polyclonal activation of human adult peripheral blood lymphocytes (PBL). J Immunol. 1985;134:1702-8.
4. 4. Toder V, Altaratz, H, Shepshelovitch J, Fein A, Nebel L. Immunoregulation of cytokines at the placenta. In: Chauat G, ed. Reproductive immunology, maternal-fetal interface relationship. vol. 154. Paris: Colloque INSERM; 1987:131-40.
5. 5. Zigril M, Fein A, Carp H, Toder V. Immunopotentiation reverses the embryotoxic effect of serum from women with pregnancy loss. Fertil Steril. 1991;56:653-9.
6. 6. Abir R, Ornoy A, Ben Hur H, Jaffe P, Pinus H. The effects of sera from women with spontaneous abortions on the in vitro development of early somite stage rat embryos. Am J Reprod Immunol. 1994;32:73-81.
7. 7. Abir R, Ornoy A, Ben Hur H, Jaffe P, Pinus H. IgG exchange as a means of partial correction of anomalies in rat embryos in vitro, induced by sera from women with recurrent abortions Toxicol in Vitro. 1993;7:816-26.
8. 8. Hill JA, Polgar K, Harlow BL, Anderson DJ. Evidence of embryo and trophoblast toxic cellular immune response(s) in women with recurrent spontaneous abortion. Am J Obstet Gynecol. 1992;166: 1042-52.
9. 9. Ferrari DA, Gilles PA, Klein NW. Sera teratogenicity to cultured rat embryos in women with histories of spontaneous abortion. Teratology. 1991;43:460.
10. 10. Fein A, Yacobovich R, Torchinsky A, Ben-Rafael Z, Carp H, Toder V. Evaluation of serum-associated embryotoxicity in women with reproductive disorders. J Assist Reprod Genet. 1995; 12:305-11.
11. 11. Jackson BW, Grund C, Schmidt E. Burki K, Franke WW, Illmansee K. Formation of cytoskeleton elements during mouse embryogenesis, intermediate filaments of the cytokeratin type and desmosomes in preimplantation embryo. Differentiation. 1980;17: 161-79.
12. 12. Speroff L, Glass RH, Kase NG. In: Mitchell C, ed. Clinical gynecology, endocrinology and infertility. Chapter 26, Female infertility, 5th ed. Baltimore: Williams and Wilkins; 1994:809-39.
13. 13. Cunningham FG, MacDonald PC, Gant NF, Leveno KG, Gilstrap LC. In: Licht J, ed. Williams obstetrics, Chapter 1, Obstetrics in broad perspective, 19th ed. East Norwalk, CT: Prantice-Hall; 1993:1-10.
14. 14. Salat-Baroux J. Recurrent spontaneous abortions. Reprod Nutr Dev. 1988;28:1555-68.
15. 15. Carp HJA, Toder V, Gazit E, Orgad S, Mashiach S, Serr DM, Nebel L. Paternal leucocyte immunization and habitual abortion. Contemp Rev Obstet Gynecol. 1988;1:49-59.
16. 16. Dokras A, Sargent IL, Redman CW, Barlow DH. Sera from women with unexplained infertility inhibit both mouse and human embryo growth in vitro. Fertil Steril. 1993;60:285-92.
17. 17. Toder V, Carp HJA, Strassburger D. Maternal immune recognition of pregnancy. Isr J Med Sci. 1994;30:902-27.
18. 18. Stern JJ, Dorfman AD, Gutierez-Najar MD, Cerillo M, Coulam CB. Frequency of abnormal karyotypes among abortuses from women with and without a history of recurrent spontaneous abortion. Fertil Steril. 1996;65:250-3.
19. 19. Beer AE, Quebbman JF, Ayers JWT, Haines RF. Major histocompatibility complex antigens. Maternal and paternal immune responses and chronic habitual abortions. Am J Obstet Gynecol. 1991;141:987-99.
20. 20. Taylor C, Page-Faulk W. Prevention of recurrent abortion with leucocyte transfusions, Lancet. 1981;2:68-9.
21. 21. Carp HJA, Toder V, Gazit E, Orgad S, Mashiach S, Serr DM. Nebel L. Selection of patients with habitual abortion for paternal leucocyte immunization. Arch Gynecol Obstet. 1990;248:93-101.
22. 22. Recurrent Miscarriage Immunotherapy Trialists Group. Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Am J Reprod Immunol. 1994;32:55-72.
23. 23. Daya S, Gunby J. The effectiveness of allogeneic leucocyte immunization in unexplained primary recurrent spontaneous abortion. Am J Reprod Immunol. 1994;32:294-302.
24. 24. Eckler JL, Laufer MR, Hall JR. Measurement of embryotoxic factors is predictive of pregnancy outcome in women with a history of recurrent abortion. Obstet Gynecol. 1993;81:84-7.
25. 25. Abir R, Usman I, Ben-Hur H, Yaffe P, Ornoy A. The effects of serum from women with miscarriages on the in vitro development of mouse preimplantation embryos. Acta Obstet Gynecol Scand. 1990;69:27-33.
26. 26. Anwar M, Macvicar J, Beck F. Evaluation of the teratogenicity of serum from patients with histories of recurrent miscarriages using an in vitro whole embryo culture technique. Br J Obstet Gynecol. 1987;94:918.
27. 27. Carp HJA, Toder V, Gazit E, Orgad S, Mashiach S, Serr DM, Nebel L. Immunization by paternal leucocytes for prevention of primary habitual abortion: results of matched controlled trial. Gynecol Obstet Invest. 1990;29:16-21.
28. 28. Coulam CB, Krysa LW, Bustillo M. Intravenous Immunoglobulin for in vitro fertilisation. Hum Reprod. 1994;9:2265-9.
29. 29. Mueller-Eckhardt G, Heine O, Polten B. IVIG to prevent recurrent spontaneous abortion. Lancet. 1991;337:424-5.
30. 30. Carp HJA, Ahiron R, Mashiach S, Schonfeld Y, Gazit E, Toder V. Intravenous immunoglobulin in women with five or more abortions. Am J Reprod Immunol. 1996;35:360-2.
31. 31. Reznikoff-Etievant MF, Simmoney M, Janaud A, Darbois Y, Netter A. Treatment of recurrent spontaneous abortions by immunization with paternal leucocytes. Lancet. 1985;1:1398.
32. 32. Mowbray JF, Underwood JL, Michel M, Forbes PW, Beard RJ. Immunization with paternal lymphocytes in women with recurrent miscarriage. Lancet. 1987;2:679-80.
33. 33. Carp HJA, Torchinsky A, Portuguese S, Gazit E, Mashiach S, Toder V, and The Recurrent Miscarriage Immunotherapy Trialists Group. Paternal leucocyte immunization after five or more miscarriages. Hum Reprod. 1997;12:250-5.
34. 34. Stern JJ, Peters AJ, Critser ES, Coulam CB. Mouse blastocyst assay (MBA). Am J Reprod Immunol. 1991;25:52.
35. 35. Roussev RG, Stern JJ, Thorsell LP, Thomason EJ, Coulam CB. Validation of an embryotoxicity assay. Am J Reprod Immunol. 1995;33:171-5.
36. 36. Austin CR. Embryo transfer and sensitivity to teratogenesis. Nature (Lond.). 1973;244:333-4.
37. 37. Takeuchi IK. Teratogenic effects of methylnitrosourea on pregnant mice before implantation. Experientia. 1984;40:879-81.
38. 38. Clerici LA, Cocco B, Sacco MG, Monteggia E, Collotta A. The use of pre-implantation mouse embryos cultured in vitro in toxicological studies. Toxicol in Vitro. 1995;5:577-81.